SANDUPHQ logo

Sandu Pharmaceuticals Ltd

SANDUPHQ·BSE·
38.26 -0.86 (-2.20%)
Market Cap36.76 Cr
PE Ratio23.91
Volume9,407
Day High - Low38.99 - 37.00
52W High-Low50.00 - 30.00
DocStoX Score
4.6/10
Weak
Fair Value
Sign in to see
ROE
4.13%
Weak
P/E
23.91x
Fair
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Weak

Price performance

Day37.00
38.99
52W30.00
50.00
DocStoX take

Supported by risk (7.0), but held back by growth (3.4).

DocStoX score

Low confidence
4.6
/10
Weak
Quality
Modest
ROE 4.1%
Valuation
Rich
P/E 23.9×
Growth
Slow
Revenue +2.8% 5Y CAGR
Risk
Moderate
D/E 0.00
Momentum
Soft
41% of 52-week range

At a glance

Market Cap
₹37 Cr
52W High / Low
₹50 / ₹30
Dividend Yield
2.70%
Promoter Holding
37.79%
EPS (TTM)
₹1.60
Book Value
₹36.48

Key highlights

  • Low leverage — D/E 0.00
  • Profitable in all of the last 5 years
  • Revenue barely growing (3% a year)
  • Small ₹37 cr company — thinner liquidity
2 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Sandu Pharmaceuticals Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.